(Q34259921)

1 August 2017

1 reference

title

Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia (English)

1 reference

1 August 2017

0 references

0 references

0 references

Mahadik SP

1

1 reference

1 August 2017

Evans D

series ordinal

2

1 reference

1 August 2017

Lal H

series ordinal

3

1 reference

1 August 2017

publication date

1 April 2001

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

1 August 2017

published in

1 reference

1 August 2017

volume

25

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

463-493

1 reference

Effect of ADP on PGE1Formation in Blood Platelets from Patients with Depression, Mania and Schizophrenia

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Vitamin E treatment of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Oxidants and antioxidants in development and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Neurological syndromes associated with antipsychotic drug use. A special report.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Docosahexaenoic acid is the preferred dietary n-3 fatty acid for the development of the brain and retina

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Superoxide-dependent and ascorbate-dependent formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Are lactoferrin and transferrin promoters of hydroxyl-radical generation?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Premorbid adjustment as predictor of outcome in schizophrenia: results of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Arachidonic acid induces a prolonged inhibition of glutamate uptake into glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Subcortical excitatory amino acid levels after acute and subchronic administration of typical and atypical neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Phosphatidyldmositol hydrolysis: A multifunctional transducing mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Advancing a neurodevelopmental origin for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Glutathione peroxidase and CT scan abnormalities in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Chronic treatment with prolixin causes oxidative stress in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Docosahexaenoic acid status of preterm infants at birth and following feeding with human milk or formula

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Astrocytosis in the molecular layer of the dentate gyrus: a study in Alzheimer's disease and schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Staining intensity of brain iron in patients with schizophrenia: a postmortem study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Schizophrenia--a brain disease? A critical review of structural and functional cerebral abnormality in the disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Oxidative stress, glutamate, and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Fat consumption and schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Lack of a bimodal distribution of ventricular size in schizophrenia: a Gaussian mixture analysis of 1056 cases and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Essential fatty acids modulate apomorphine activity at dopamine receptors in cat caudate slices

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Prenatal growth markers in schizophrenia: a monozygotic co-twin control study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Ventricular enlargement in poor-outcome schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Neurobiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Volumes of Ventricular System Subdivisions Measured From Magnetic Resonance Images in First-Episode Schizophrenic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

31phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Left ventricular enlargement associated with diagnostic outcome of schizophreniform disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

The lipid membrane hypothesis of schizophrenia: implications for possible clinical breath tests

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids: a study of normal subjects from Italy, Finland, and the USA.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Postmortem studies of the hippocampal formation in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Cytotoxicity and genotoxicity of lipid-oxidation products

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Mental illness in adults with fetal alcohol syndrome or fetal alcohol effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Cortical pruning and the development of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Possible association of schizophrenia with a disturbance in prostaglandin metabolism: a physiological hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Maternal smoking during pregnancy and psychiatric adjustment in late adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

The detection of schizophrenia in infancy; a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Neurobiologic antecedents of schizophrenia in children. Evidence for an inherited, congenital neurointegrative defect.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Infants at risk for schizophrenia: sequelae of a genetic neurointegrative defect. A review and replication analysis of pandysmaturation in the Jerusalem Infant Development Study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Increased platelet phospholipase A2 activity in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Alcohol dependence and hospitalization in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Reactive oxygen species and the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Neuropathology of schizophrenia: cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Schizophrenia as a prostaglandin deficiency disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Is the main problem in free radical damage caused by radiation, oxygen and other toxins the loss of membrane essential fatty acids rather than the accumulation of toxic materials?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

The relationship between schizophrenia and essential fatty acid and eicosanoid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Schizophrenia as a membrane lipid disorder which is expressed throughout the body

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Prostaglandins and schizophrenia: further discussion of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

The membrane hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Fatty acid levels in the brains of schizophrenics and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Role of gangliosides in behavioral and biochemical actions of alcohol: cell membrane structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Prenatal developmental disturbances in the limbic allocortex in schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Three-dimensional cortical morphometry of the planum temporale in childhood-onset schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Cerebral ventricular enlargement in schizophreniform disorder does not progress. A seven year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Study of neuropathologic changes in the striatum following 4, 8 and 12 months of treatment with fluphenazine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Neuronal apoptosis: current understanding of molecular mechanisms and potential role in ischemic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Accumulation of diacylgylcerol in platelet phosphoinositide turnover in schizophrenia: a biological marker of good prognosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Elevated plasma prostaglandin E2 levels in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

No differences in phospholipase-A2 activity between acute psychiatric patients and controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Ventricle-to-brain ratio in schizophrenia: a controlled follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Erythrocyte membrane phospholipids in psychotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

First-episode studies in schizophrenia: criteria and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Heterogeneity of the psychoses: is there a neurodegenerative psychosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

The anthropometric assessment of dysmorphic features in schizophrenia as an index of its developmental origins.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Differential effects of olanzapine on the gene expression of superoxide dismutase and the low affinity nerve growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Free radical scavenging enzyme activity and related trace metals in clozapine-induced agranulocytosis: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Qualitative assessment of brain morphology in acute and chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

CSF Prostaglandin Levels in Depressed and Schizophrenic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Alpha-tocopherol in tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Smoking and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Increased manganese-superoxide dismutase activity in postmortem brain from neuroleptic-treated psychotic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Free radical pathology and antioxidant defense in schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Cultured skin fibroblasts as a cell model for investigating schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Oxidative injury and potential use of antioxidants in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Haloperidol alters rat CNS cholinergic system: enzymatic and morphological analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Plasma membrane phospholipid and cholesterol distribution of skin fibroblasts from drug-naive patients at the onset of psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Elevated plasma lipid peroxides at the onset of nonaffective psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Abnormal growth of skin fibroblasts from schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Decreased adhesiveness and altered cellular distribution of fibronectin in fibroblasts from schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Utilization of precursor essential fatty acids in culture by skin fibroblasts from schizophrenic patients and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Aspects of oxidative metabolism in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Programmed cell death: implications for neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Plasma prostaglandin E2 metabolite--measured as 11-deoxy-15-keto-13,14-dihydro-11 beta,16 xi-cyclo-PGE2--in twins with schizophrenic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Schizophrenic symptoms and dietary intake of n-3 fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

The Nithsdale Schizophrenia Surveys. 16. Breast-feeding and schizophrenia: preliminary results and hypotheses.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

The Nithsdale Schizophrenia Surveys. XIV: Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia, and in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Glutamate-induced apoptosis results in a loss of striatal neurons in the parkinsonian rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Impaired antioxidant defense at the onset of psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Progression of cerebroventricular enlargement and the subtyping of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Elevated PLA2 activity in schizophrenics and other psychiatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Excitotoxic amino acids and neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Glutamate receptor dysfunction and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Childhood patterns predictive of adult schizophrenia: a 30-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Prenatal exposure to maternal stress and subsequent schizophrenia. The May 1940 invasion of The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Evidence of enhanced lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Electrophysiological correlates of peroxide damage in guinea pig hippocampus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Volatile organic compounds in the breath of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Deterioration of spatial and nonspatial reference and working memory in aged rats: protective effect of life-long calorie restriction.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Postmortem studies in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Neurologic soft signs in schizophrenia and character disorders. Organicity in schizophrenia with premorbid asociality and emotionally unstable character disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Schizophrenia as a developmental disorder of the cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Peroxidation induced changes in synaptosomal transport of dopamine and gamma-aminobutyric acid

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Enzymes of the antioxidant defense system in chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Free radical pathology in schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Influence of lipid peroxidation on [3H]ketanserin binding to 5-HT2 prefrontal cortex receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Current status of antioxidant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Free radicals in the genesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Effects of chlorpromazine on the activities of antioxidant enzymes and lipid peroxidation in the various regions of aging rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Prostaglandins and thromboxanes

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Regulation of gamma-aminobutyric acid/barbiturate receptor-gated chloride ion flux in brain vesicles by phospholipase A2: possible role of oxygen radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Oxidative stress in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Omega-3 fatty acids in health and disease and in growth and development

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Metabolism of Oxygen Derivatives in Down's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Depression After Transient Ischemic Attack: A Clinically Distinct Subtype of Vascular Depression?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Vitamin C status in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Penicillin and essential fatty acid supplementation in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Dyskinesias and their treatment with essential fatty acids: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Conformational changes in oxidized phospholipids and their preferential hydrolysis by phospholipase A2: a monolayer study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Polyunsaturated fatty acids, prostaglandins, and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Stability of cerebral ventricular size from the appearance of the first psychotic symptoms to the later diagnosis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Do essential fatty acids play a role in brain and behavioral development?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

On the plausibility of "the neurodevelopmental hypothesis" of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

gamma-Tocopherol: an efficient protector of lipids against nitric oxide-initiated peroxidative damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Progressive ventricular enlargement in schizophrenia: comparison to bipolar affective disorder and correlation with clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

MRI brain abnormalities in chronic schizophrenia: one process or more?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Early intervention for schizophrenia: can the course of the illness be altered?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Increased turnover of platelet phosphatidylinositol in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Protein oxidation associated with aging is reduced by dietary restriction of protein or calories

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

Size, shape, and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900181-0

7 January 2021

10.1016/S0278-5846(00)00181-0

Identifiers

DOI

1 reference

1 August 2017

1 reference